Your browser doesn't support javascript.
loading
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2.
Yamamoto, Shohei; Matsuda, Kouki; Maeda, Kenji; Oshiro, Yusuke; Inamura, Natsumi; Mizoue, Tetsuya; Konishi, Maki; Takeuchi, Junko S; Horii, Kumi; Ozeki, Mitsuru; Sugiyama, Haruhito; Mitsuya, Hiroaki; Sugiura, Wataru; Ohmagari, Norio.
Afiliación
  • Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. syamamoto@hosp.ncgm.go.jp.
  • Matsuda K; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Maeda K; Japan Foundation for AIDS Prevention, Tokyo, Japan.
  • Oshiro Y; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
  • Inamura N; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
  • Mizoue T; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Konishi M; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Takeuchi JS; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Horii K; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. mizoue@hosp.ncgm.go.jp.
  • Ozeki M; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Sugiyama H; Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mitsuya H; Infection Control Office, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Sugiura W; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
BMC Infect Dis ; 23(1): 282, 2023 May 04.
Article en En | MEDLINE | ID: mdl-37142992
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Epidemias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Epidemias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido